Zorbtive information request

Zorbtive [somatropin (rDNA origin) for injection]

How SeroCare^SM
can help Zorbtive patients

Helpful information for people with SBS considering Zorbtive treatment

Clinical information about Zorbtive for health professionals

Clinical opinions about Zorbtive and goals of treatment for Short Bowel Syndrome

Glossary

Links

Home

Clinical Information Request Form

Fill out the simple form below, and the information you request about Zorbtive® [somatropin (rDNA origin) for injection] will be sent to your office, and forwarded to your e-mail address as a printable PDF. (Note: the journal article referenced below is available in printed form only.)

Make sure to check mark the specific information you wish to receive.

Clinical Information Request Form for Health Professionals

Salutation

First name

Last name

Address

City

State

Zip code

Phone

E-mail

Type of practice

If other,
please specify

Licensed in which state

Hospital
affiliations

Number of SBS patients on PN

The information requested will be sent to your office, both as a printable PDF and as printed material.

	Statement of Medical Necessity			Understanding Zorbtive Treatment - a patient handbook
	A Treatment Guideline for Zorbtive			Zorbtive Full Prescribing Information and Patient Information Leaflet
	A Clinical Review for Zorbtive			Annals of Surgery (2005) journal article “Growth Hormone, Glutamine, and an Optimal Diet Reduces Parenteral Nutrition in Patients with Short Bowel Syndrome” —Byrne, et al. Vol 242, November 2005, pp 665–661. This is the journal article where Zorbtive pivotal trial data were published (available in printed form only).

Type the following: For security purposes, please type the letters in the image.

How SeroCare^SM can help Zorbtive patients
Helpful information for people with SBS, considering Zorbtive treatment
Clinical information about Zorbtive for health professionals
Clinical opinions about Zorbtive and goals of treatment for Short Bowel Syndrome
Glossary
Links
Home

Zorbtive® [somatropin (rDNA origin) for injection] is indicated for the treatment of Short Bowel Syndrome (SBS) in patients receiving specialized nutritional support. Optimal management of SBS may include dietary adjustments, enteral feedings, parenteral nutrition, and fluid and micronutrient supplements, as needed.

Some common side effects of Zorbtive treatment include muscle and joint pain, and fluid retention (swelling).

Zorbtive may also cause serious side effects such as inflammation of the pancreas (pancreatitis), diabetes or
other blood sugar problems, pain, numbness or tingling in the wrist and hand, or increased blood pressure
in the brain. Make sure and talk with your doctor about these side effects.

Do not take Zorbtive if you have any of the following serious medical conditions: open-heart surgery; stomach-area (abdominal) surgery; an accident; breathing problems (respiratory failure); cancer; or, allergy to Zorbtive or other growth hormone medications.

This information is not intended to replace discussions with your healthcare professional.
For additional information about Zorbtive, please read the Zorbtive Patient Information Leaflet
and Zorbtive Full Prescribing Information and talk to your doctor. You can also call SeroCare^SM
toll free at 800-714-2437. Zorbtive is available by prescription only.

This Web site was developed by EMD Serono, Inc. (emdserono.com), makers of Zorbtive, to educate SBS patients
and interested healthcare professionals about this treatment for Short Bowel Syndrome.

This site contains medical information that is intended for residents of the United States
only and is not meant to substitute for the advice provided by a medical professional.
Always consult a doctor if you have health concerns. Use and access of this
site is subject to the terms and conditions as set out in our Legal Statement
and Privacy Policy.